Bright Peak Therapeutics reports on Treg enhancer autoimmune disease programs
Nov. 7, 2022
Interleukin-2 (IL-2) plays essential roles in immune system function, controlling tolerance and immunity. From the thymus, IL-2 prevents autoimmune disease by promoting the differentiation of immature T cells to regulatory T cells (Tregs).